Shots:
In the next installment of Dealmaker 2023, we bring an informative report on the Top M&A based on the Deal Value
The report revolves around Pfizer, which signed 16 collaborations comprising acquisitions, contract services, development & commercialization, license, R&D, and product purchases that have summed to a total of $63.23B
Propelled by the invaluable…
